Franklin Resources
AKBA icon

Franklin Resources’s Akebia Therapeutics AKBA Stock Holding History

Franklin Resources’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.8K Sell
37,301
-144,318
-79% -$198K ﹤0.01% 3004
2025
Q4 		$292K Sell
181,619
-2,498,569
-93% -$5.23M ﹤0.01% 2636
2025
Q3 		$7.32M Buy
2,680,188
+12,776
+0.5% +$42.5K ﹤0.01% 1274
2025
Q2 		$9.71M Buy
2,667,412
+85
+0% +$234 ﹤0.01% 1145
2025
Q1 		$5.12M Buy
2,667,327
+2,500,143
+1,495% +$5.1M ﹤0.01% 1338
2024
Q4 		$318K Hold
167,184
– – ﹤0.01% 2482
2024
Q3 		$221K Buy
+167,184
New +$223K ﹤0.01% 2608
2024
Q1 		– Sell
-65,083
Closed -$80.7K – 2862
2023
Q4 		$80.7K Hold
65,083
– – ﹤0.01% 2494
2023
Q3 		$74.2K Sell
65,083
-17,390
-21% -$22.3K ﹤0.01% 2491
2023
Q2 		$75.5K Hold
82,473
– – ﹤0.01% 2571
2023
Q1 		$46.2K Hold
82,473
– – ﹤0.01% 2195
2022
Q4 		$47.6K Hold
82,473
– – ﹤0.01% 2220
2022
Q3 		$26K Hold
82,473
– – ﹤0.01% 2243
2022
Q2 		$29K Sell
82,473
-39,922
-33% -$16.8K ﹤0.01% 2286
2022
Q1 		$88K Buy
122,395
+697
+0.6% +$1.49K ﹤0.01% 2315
2021
Q4 		$275K Sell
121,698
-302
-0.2% -$823 ﹤0.01% 2116
2021
Q3 		$351K Buy
+122,000
New +$348K ﹤0.01% 2030
2015
Q1 		– Sell
-86,500
Closed -$1.01M – 1582
2014
Q4 		$1.01M Sell
86,500
-335,000
-79% -$4.8M ﹤0.01% 1388
2014
Q3 		$9.33M Sell
421,500
-88,900
-17% -$2.04M ﹤0.01% 1053
2014
Q2 		$14.2M Buy
+510,400
New +$12.3M 0.01% 968

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Franklin Resources's AKBA Position: Q1 2026 in Review

Franklin Resources reduced its Akebia Therapeutics (AKBA) stake by 79% in Q1 2026, selling an estimated $198K and leaving 37,301 shares worth $51.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3004.

Franklin Resources first reported a position in AKBA in Q2 2014 and has held it in 20 quarters since. The position peaked at $14.2M in Q2 2014. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Franklin Resources held 37,301 shares of Akebia Therapeutics worth $51.8K as of Q1 2026.
  • Franklin Resources sold 144,318 Akebia Therapeutics shares in Q1 2026, an estimated $198K.
  • Akebia Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #3004 holding.
  • Franklin Resources first reported a position in Akebia Therapeutics in Q2 2014 and has held it in 20 quarters since.
  • Franklin Resources's Akebia Therapeutics position peaked at $14.2M in Q2 2014.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.